2011
DOI: 10.1016/j.antiviral.2011.08.006
|View full text |Cite
|
Sign up to set email alerts
|

Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
7
0
3

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 61 publications
0
7
0
3
Order By: Relevance
“…The sequence encoding for NcPRO was previously cloned into a pCI‐Neo vector (Promega, Madison, WI, USA) and fused downstream the 212 amino acid of VSV‐G, which was already cloned in pCDNA3.1 (VSV‐G∆212 ). A new forward primer with NcoI restriction site (5′‐GTGACCATGGACTGGGATCCCGTTGTCAAG‐3′) and a reverse primer with an XbaI site (5′‐GCTCTAGATCACTAATAGCCAGACTGGTGAAGG‐3′) were designed.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The sequence encoding for NcPRO was previously cloned into a pCI‐Neo vector (Promega, Madison, WI, USA) and fused downstream the 212 amino acid of VSV‐G, which was already cloned in pCDNA3.1 (VSV‐G∆212 ). A new forward primer with NcoI restriction site (5′‐GTGACCATGGACTGGGATCCCGTTGTCAAG‐3′) and a reverse primer with an XbaI site (5′‐GCTCTAGATCACTAATAGCCAGACTGGTGAAGG‐3′) were designed.…”
Section: Methodsmentioning
confidence: 99%
“…For that purpose, we fused NcPRO with the N‐terminal portion of the vesicular stomatitis virus glycoprotein G (VSV‐G) sequence, providing functional bovine T‐cell epitopes. We have demonstrated before that the association of short peptides to N‐terminal sequences of VSV‐G can enhance T‐cell responses to the third party antigen in bovines . The aim of this approach was to activate naïve T cells, which are difficult to tackle due to the highly variable bovine major histocompatibility complex (BoLA) …”
Section: Introductionmentioning
confidence: 99%
“…106 The antibody isotype, the avidity of the antibody to the virus in question, and the type of immune response elicited are also important factors to consider. [107][108][109] In a recent study comparing the accuracy of traditional and novel serological assays to predict cross-protection, it was found that the use of VNT titers and r 1 -values are inaccurate indicators of protection. 110 However, when the VNT titers were combined with the IgG1 titer, a more accurate estimate of FMD vaccine protection against the heterologous virus for serotype A was achieved.…”
mentioning
confidence: 99%
“…Asimismo, desde hace muchos años se generan y aplican los avances en el estudio de los epitopes relevantes, en particular mediante el empleo de secuencias en tándem. Capozzo y colaboradores [162] obtuvieron buenos resultados al inmunizar ganado con vacunas a DNA y peptídicas producidas mediante el sistema BV-células de insecto. En ambos casos las vacunas contenían varias repeticiones del sitio A. Más recientemente se han desarrollado Discusión general vacunas a péptidos dendriméricos conteniendo epitopes B, cuyas respuestas fueron mejoradas por el agregado de epitopes T [181], [182].…”
Section: Discusión Generalunclassified
“…Teniendo en cuenta los resultados del capítulo I, en el que se determinó que los epitopes B generan la máxima respuesta humoral cuando son expuestos en alta densidad en toda la superficie del virión brotado, mientras que la mayor respuesta citotóxica generada contra epitopes T se logra mediante la presentación en cápside, el antígeno a ser transportado en la superficie del virión brotado contendrá los epitopes más relevantes ya descriptos y caracterizados en dicha cepa. Considerando también los antecedentes exitosos de expresión en tándem de sitios antigénicos[162], se diseñó un antígeno multiepitópico (AgME) que contiene tres copias del Sitio A (aa 14 a 160 de VP1), dos copias del Sitio C (aa 200 a 213 de VP1) y una copia de los de aa 41 a 60 de V P l.L a figura a continuación muestra un esquema del AgME cuya síntesis fue solicitada a IDT -Biodynamics. La secuencia nucleotídica y aminoacídica completa se encuentra en los anexos.…”
unclassified